0001209191-20-044365.txt : 20200731
0001209191-20-044365.hdr.sgml : 20200731
20200731210526
ACCESSION NUMBER: 0001209191-20-044365
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191218
FILED AS OF DATE: 20200731
DATE AS OF CHANGE: 20200731
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cho Man
CENTRAL INDEX KEY: 0001797605
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 201067600
MAIL ADDRESS:
STREET 1: C/O ONCTERNAL THERAPEUTICS, INC.
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2019-12-18
2019-12-23
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001797605
Cho Man
12230 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
1
0
0
0
Stock Option
4.11
2019-12-18
4
A
0
30000
0.00
A
2029-12-18
Common Stock
30000
30000
D
The original Form 4 reported the acquisition of the Stock Options in the "D" column of Column 5. This amendment is being filed to correctly report the acquisition of the Stock Options in the "A" column of Column 5.
One thirty-sixth of each Effective Date Award and each Initial Award shall vest and become exercisable in substantially equal installments on each monthly anniversary of the date of grant, so that the options subject to each such type of award shall be fully vested on the three-year anniversary of the date of grant, subject to the Reporting Persons continued service on the Board through each such vesting date.
/s/ Hazel M. Aker, Attorney-in-fact
2020-07-31